Bioethics of Gene Therapy

Abstract

Gene therapy in human beings raises a variety of important ethical, legal and social issues. Somatic gene therapy (SGT) is similar to other forms of medical treatment in that the goal is to treat or prevent diseases in individuals. SGT raises questions concerning safety and efficacy of treatments and protection for human research subjects. Germline gene therapy is different from traditional medicine because it involves manipulation of the human genome to prevent the birth of children with genetic diseases. Germline gene therapy has been much more controversial than SGT, because it creates risks not only to patients but also to future generations, and because it may lead to genetic enhancement. Genetic enhancement raises a number of difficult issues, including the ethics of changing human traits, parental control over children's lives, exacerbation of discrimination and social inequalities and eugenics.

Key Concepts:

  • Advances in genetics and biotechnology in the 1970s and 1980s made possible the first somatic gene therapy experiments, which took place in the 1990s.

  • Somatic gene therapy has had some successes but still faces significant technical challenges.

  • Somatic gene therapy can pose significant risks to patients and some have died in somatic gene therapy experiments.

  • Germline gene therapy has been more controversial than somatic gene therapy because it involves deliberate, inheritable changes in the genome.

  • Germline gene therapy poses risks not only to patients but also to future generations.

  • Germline gene therapy raises difficult ethical questions related to tampering with human nature, enhancing human traits, parental control over children, discrimination, social justice and eugenics.

  • The distinction between therapy (which aims to prevent or treat disease) and enhancement (which aims to improve human traits), plays a key role in debates about gene therapy.

  • The therapy/enhancement distinction is not as clear as some have assumed, because the concept of disease is not purely objective and includes social, cultural and ethical dimensions.

  • Investigators and institutions should take appropriate steps to protect the rights and welfare of gene therapy patients participating in clinical research.

  • In thinking about the balance of benefit and risks of a gene therapy study, it is important to consider the safety and efficacy of the proposed research and the availability of alternatives.

Keywords: somatic gene therapy; germline gene therapy; human enhancement; bioethics; human subjects research; assisted reproduction

References

Baylis F and Robert JS (2004) The inevitability of genetic enhancement technologies. Bioethics 18(1): 1–26.

Buchanan A, Brock D, Daniels N and Wikler D (2001) From Chance to Choice: Genetic and Justice. Cambridge: Cambridge University Press.

Dresser R (2004) Designing babies: human research issues. IRB 26(5): 1–8.

Fukuyama F (2003) Our Posthuman Future: Consequences of the Biotechnology Revolution. New York: Picador.

Glover J (2009) Choosing Children: Genes, Disability and Design. New York: Oxford University Press.

Green R (2008) Babies by Design: The Ethics of Genetic Choice. New Haven, CT: Yale University Press.

Harris J (2010) Enhancing Evolution: The Ethical Case for Making Better People. Princeton, NJ: University Press.

Kimmelman J (2009) Gene Transfer and the Ethics of First‐in‐Human Research. Cambridge: Cambridge University Press.

McElhenry VK (2010) Drawing the Map of Life: Inside the Human Genome Project. New York: Basic Books.

Nelkin D and Lindee S (2004) The DNA Mystique: The Gene As Cultural Icon. Ann Arbor, MI: University of Michigan Press.

Resnik DB (2004) Owning the Genome: A Moral Analysis of DNA Patenting. Albany, NY: State University of New York Press.

Resnik DB, Steinkraus H and Langer P (1998) Human Germline Gene Therapy: Scientific, Ethical, and Political Issues. Austin, TX: RG Landes Bioscience.

Sandel M (2009) The Case Against Perfection: Ethics in the Age of Genetic Engineering. Cambridge, MA: Harvard University Press.

Shamoo AS and Resnik DB (2009) Responsible Conduct of Research, 2nd edn. New York: Oxford University Press.

Silver L (2007) Remaking Eden: How Genetic Engineering and Cloning will Transform the American Family. New York: Harper Perennial.

Walters L and Palmer J (1997) The Ethics of Human Gene Therapy. New York: Oxford University Press.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Resnik, David B(Mar 2012) Bioethics of Gene Therapy. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0003480.pub2]